Trainee Pearls podkast

#18 Jurjen Versluis: Transplant for high-risk MDS

29.10.2023
0:00
20:34
Do tyłu o 15 sekund
Do przodu o 15 sekund

Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival. The authors evaluated the impact of MDS genetics on the benefit of HCT in a biological assignment (donor v no donor) study. https://pubmed.ncbi.nlm.nih.gov/37607457/ ALSO AS VIDEO ON https://youtu.be/JbHS_-2sJQc CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/CarmeloGurnari


Więcej odcinków z kanału "Trainee Pearls"